|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaudhary UB and Haldas JR: Long-term
complications of chemotherapy for germ cell tumours. Drugs.
63:1565–1577. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brouwers EE, Huitema AD, Beijnen JH and
Schellens JH: Long-term platinum retention after treatment with
cisplatin and oxaliplatin. BMC Clin Pharmacol. 8:72008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang YT, Huang DM, Chueh SC, Teng CM and
Guh JH: Alisol B acetate, a triterpene from Alismatis rhizoma,
induces Bax nuclear translocation and apoptosis in human
hormone-resistant prostate cancer PC-3 cells. Cancer Lett.
231:270–278. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oral O, Akkoc Y, Bayraktar O and Gozuacik
D: Physiological and pathological significance of the molecular
cross-talk between autophagy and apoptosis. Histol Histopathol.
31:479–498. 2016.PubMed/NCBI
|
|
6
|
Crowell JA: The chemopreventive agent
development research program in the Division of Cancer Prevention
of the US National Cancer Institute: An overview. Eur J Cancer.
41:1889–1910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mann J: Natural products in cancer
chemotherapy: Past, present and future. Nat Rev Cancer. 2:143–148.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee AY, Park JY, Chun JM, Moon BC, Kang
BK, Seo YB, Shin HK and Kim HK: Optimization of extraction
condition for alisol B and alisol B acetate in alismatis rhizoma
using response surface methodology. J Liq Chromatogr Relat Technol.
36:513–524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Law BY, Wang M, Ma DL, Al-Mousa F,
Michelangeli F, Cheng SH, Ng MH, To KF, Mok AY, Ko RY, et al:
Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic
reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic
reticulum stress, and apoptosis. Mol Cancer Ther. 9:718–730. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu W, Li T, Qiu JF, Wu SS, Huang MQ, Lin
LG, Zhang QW, Chen XP and Lu JJ: Anti-proliferative activities of
terpenoids isolated from Alisma orientalis and their
structure-activity relationships. Anticancer Agents Med Chem.
15:228–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang ZY, Zhang XM, Zhang FX, Liu N, Zhao
F, Zhou J and Chen JJ: A New triterpene and anti-hepatitis B virus
active compounds from Alisma orientalis. Planta Med. 72:951–954.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin HG, Jin Q, Ryun Kim A, Choi H, Lee JH,
Kim YS, Lee DG and Woo ER: A new triterpenoid from Alisma orientale
and their antibacterial effect. Arch Pharm Res. 35:1919–1926. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Feng L, Ma L, Chen H, Tan X, Hou
X, Song J, Cui L, Liu D, Chen J, et al: Alisol a 24-acetate and
alisol B 23-acetate induced autophagy mediates apoptosis and
nephrotoxicity in human renal proximal tubular cells. Front
Pharmacol. 8:1722017.PubMed/NCBI
|
|
14
|
Xiong Y, Huang BY and Yin JY:
Pharmacogenomics of platinum-based chemotherapy in non-small cell
lung cancer: Focusing on DNA repair systems. Med Oncol. 34:482017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang L, Yang C, Li C, Zhao Q, Liu L, Fang
X and Chen XY: Recent advances in biosynthesis of bioactive
compounds in traditional Chinese medicinal plants. Sci Bull
(Beijing). 61:3–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu W, Li X, Lin N, Zhang X, Huang X, Wu T,
Tai Y, Chen S, Wu CH, Huang M and Wu S: Pharmacokinetics and tissue
distribution of five major triterpenoids after oral administration
of Rhizoma Alismatis extract to rats using ultra high-performance
liquid chromatography-tandem mass spectrometry. J Pharm Biomed
Anal. 146:314–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Li XY, Lin N, Zhao WL, Huang XQ,
Chen Y, Huang MQ, Xu W and Wu SS: Diuretic activity of compatible
triterpene components of alismatis rhizoma. Molecules. 22(pii):
E14592017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Matsuda H, Kageura T, Toguchida I,
Murakami T, Kishi A and Yoshikawa M: Effects of sesquiterpenes and
triterpenes from the rhizome of Alisma orientale on nitric oxide
production in lipopolysaccharide-activated macrophages: Absolute
stereostructures of alismaketones-B 23-acetate and -C 23-acetate.
Bioorg Med Chem Lett. 9:3081–3086. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang A, Sheng Y and Zou M:
Antiproliferative activity of Alisol B in MDA-MB-231 cells is
mediated by apoptosis, dysregulation of mitochondrial functions,
cell cycle arrest and generation of reactive oxygen species. Biomed
Pharmacother. 87:110–1107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang LL, Xu YL, Tang ZH, Xu XH, Chen X,
Li T, Ding CY, Huang MQ, Chen XP, Wang YT, et al: Effects of alisol
B 23-acetate on ovarian cancer cells: G1 phase cell cycle arrest,
apoptosis, migration and invasion inhibition. Phytomedicine.
23:800–809. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Melo-Lima S, Lopes MC and Mollinedo F:
ERK1/2 acts as a switch between necrotic and apoptotic cell death
in ether phospholipid edelfosine-treated glioblastoma cells.
Pharmacol Res. 95-96:2–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao Y, Li ETS and Wang M: Alisol B
23-acetate induces autophagic-dependent apoptosis in human colon
cancer cells via ROS generation and JNK activation. Oncotarget.
8:70239–70249. 2017.PubMed/NCBI
|
|
23
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujimura K, Choi S, Wyse M, Strnadel J,
Wright T and Klemke R: Eukaryotic translation initiation factor 5A
(EIF5A) regulates pancreatic cancer metastasis by modulating RhoA
and Rho-associated kinase (ROCK) protein expression levels. J Biol
Chem. 290:29907–29919. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morgan TM, Koreckij TD and Corey E:
Targeted therapy for advanced prostate cancer: Inhibition of the
PI3K/Akt/mTOR pathway. Curr Cancer Drug Targets. 9:237–249. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martin KA and Blenis J: Coordinate
regulation of translation by the PI 3-kinase and mTOR pathways. Adv
Cancer Res. 86:1–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Surviladze Z, Sterk RT, DeHaro SA and
Ozbun MA: Cellular entry of human papillomavirus type 16 involves
activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway
and inhibition of autophagy. J Virol. 87:2508–2517. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Foster KG and Fingar DC: Mammalian target
of rapamycin (mTOR): Conducting the cellular signaling symphony. J
Biol Chem. 285:14071–14077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu W, Sun H, Zha W, Cui W, Xu L, Min Q and
Wu J: Apigenin attenuates adriamycin-induced cardiomyocyte
apoptosis via the PI3K/AKT/mTOR pathway. Evid Based Complement
Alternat Med. 2017:25906762017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang J, Pi C and Wang G: Inhibition of
PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy
in hepatocellular carcinoma cells. Biomed Pharmacother.
103:699–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
